Bill Cavanagh

1PUBLICATIONS
2CO-AUTHORS
Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 30, 2021
A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease.

David McMullin, David Clark, Bill Cavanagh

Pageof 1